Today, we launched our patient registry and are accepting submissions from individuals with treatment-resistant depression (TRD) who may be interested in learning about potential future research opportunities.
Sign up here 👉 registry.motifneuro.tech
The root cause for mental illness for many people is a circuit in the brain that's not acting the way it should. As engineers and scientists, who understand the circuits inside the brain, we can design the technologies to repair the circuits underlying the illness.
Big thank you to Advanced Research Projects Agency for Health (ARPA-H) for visiting Motif HQ.
ARPA-H supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative health solutions for all.
Do you think the next moonshot is in mental health? We do. 🌝
Thanks to Astro Teller of X, the Moonshot Factory, for visiting @jacobrobinson.bsky.social lab at @riceneuro.bsky.social
Motif Neurotech CEO and Co-Founder @jacobrobinson.bsky.social will be speaking at the 2025 New York Brain-Computer Interface Symposium (NYBCI). Register at nybci.com Moderated by @bloomberg.com @ikeswetlitz.bsky.social
We always love @onemindorg.bsky.social Music Festival!! We're grateful to be a part of this mission-aligned community! #Music4BrainHealth @jacobrobinson.bsky.social
What I’m reading 👉📚 A powerful & personal piece by
@jacobrobinson.bsky.social (CEO @motifneuro.bsky.social) on how brain-computer interfaces could transform mental health.
Honest, bold & inspiring. I encourage folks to read & subscribe. brainjacob.substack.com
#BCIs #BrainComputerInterface
Yesterday, we spent the day on Capitol Hill 🇺🇸 for the Rally for Medical Research. Jon Nelson joined our friends from
@onemindorg.bsky.social
to march and meet in support of making medical research a national priority.
Today is World Suicide Prevention. Motif stands with our community today to shine a light on suicide and because the silence and stigma in our society only increases the danger of this disease💡.
Let's change the narrative so we can get well and stay well, together 🫂.
🇬🇧 Welcome and congrats to our first international employee, Sudam Dias! 🇬🇧
Based in London, Sudam will work closely with our partners at MintNeuro as we advance neural ASIC development through our collaboration with Advanced Research + Invention Agency (ARIA).
Andrew graduated from MIT with a B.S. in Physics and Biology. He completed his MD/PhD at Columbia University working in computational biology of cancer immunotherapy. His research interests include digital phenotyping, clinical use of LLMs, and precision medicine within psychiatry.
We’re thrilled to welcome Andrew Chen, MD, PhD to our team as a Senior Scientist!
Andrew is a psychiatrist and will specialize in machine learning at Motif. He'll also work closely with our Community Advisory Board to integrate our lived experience experts into clinical efforts.
@jacobrobinson.bsky.social explores the history and future of regulating our biology with technology on the MARS stage.
How can we usher in an era where technological interfacing with our brains is as commonplace and successful as pacemakers are used in our hearts? What are the roadblocks in our way?
As we continue advancing into a technology-enhanced future, can we create and then accept novel technologies that do a better job?
We all want to regulate our brain activity. Quite often we utilize substances and activities to try and achieve this even if they don't work very well or have negative side effects. We turn to antiquated solutions because they are safe and familiar 🧵
It’s a long road for someone suffering from severe mental illness. Antidepressants, TMS sessions at a clinic, ketamine, ECT. A plethora of antiquated options that leave patients still searching for relief. “How is this real?”
Our next #InterfaceNeuroGT session highlighted cutting-edge techniques for measuring and manipulating sensorimotor and cognitive behavior — across species and across scales.
Sponsored by McCamish Parkinson's Disease Innovation Program and chaired by @drannabellesinger.bsky.social.
We believe it reflects the dedication and effort our team has put in over the past several years. Jacob had the chance to present our prototype DOT on stage and describe our progress building neural devices to help people live better lives.
📸: Benjamin Rose Photography
For those unfamiliar, it's a semi-secret, invitation-only event for about 160 guests hosted by Jeff Bezos. It champions a hopeful outlook on scientific breakthroughs to propel a new era of innovation. We were incredibly honored to receive the invitation.
Last month, we had the privilege of being invited to share our advancements and our vision for the future of mental health care at the MARS conference.
Check out the view from Deep Tech Week NYC this week 🏙️ 😮💨. @jacobrobinson.bsky.social shared the stage with some great neurotech leaders for an evening of networking and industry collaboration.
Shoutout to Psymed, Data Joint and Actual VC for hosting such a wonderful night!
Deeply grateful for my recent visits to @riceneuro.bsky.social, @bcmhouston.bsky.social, and @motifneuro.bsky.social! The passion for innovation and collaboration in the neuroscience research community is truly inspiring.
Thanks for the opportunity to share the ongoing projects from our lab!
Our COO Nick Halper recently sat down with on Ones Changing the World Podcast 🔊
They discuss DOT - Motif's therapeutic neural device technology and our place in the broader brain-computer interfaces (#BCI) ecosystem.
youtu.be/XqiiCWw1Cr0?...
Please join us in congratulating Julie Goode on her promotion to Vice President of Clinical Affairs! Julie will continue to lead our clinical research efforts as we prepare for clinical trials in 2025! 🚀
